Dana Free
Family · Northport, ALNPI 1164855136
Payments from drug & device makers
Across 176 payments — averaging $22.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$728
- Novo Nordisk$511
- GSK$408
- Lilly USA, LLC$221
- Otsuka America Pharmaceutical, Inc.$211
- plus $792 from 17 others
What the payments were for
- Food & beverage$3,956100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $1,086 |
| AstraZeneca | 30 | $728 |
| Novo Nordisk | 20 | $511 |
| GSK | 16 | $408 |
| Lilly USA, LLC | 13 | $221 |
| Otsuka America Pharmaceutical, Inc. | 9 | $211 |
| Amgen | 3 | $133 |
| Corcept Therapeutics | 4 | $100 |
| Atland Pharmaceuticals, LLC | 1 | $96 |
| Corium, LLC | 7 | $82 |
| Astellas Pharma US Inc | 3 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $44 |
| Sanofi Pasteur Inc. | 2 | $40 |
| Abbott | 2 | $38 |
| Pfizer | 2 | $37 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| UCB, Inc. | 1 | $28 |
| Medline Industries LP | 1 | $22 |
| Sobi, Inc | 1 | $21 |
| Exact Sciences | 1 | $15 |
| Novartis | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,956 in reported general payments places this provider in the 85th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 215 | $2,143 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 153 | $1,542 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $824 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 42 | $742 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 31 | $611 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 47 | $588 |
| Losartan Potassium | 29 | $467 |
| Rosuvastatin Calcium | 23 | $409 |
| Tramadol Hcl | 111 | $377 |
| Atorvastatin Calcium | 23 | $334 |
| Alprazolam | 90 | $297 |
| Metoprolol Succinate | 17 | $285 |
| Pantoprazole Sodium | 27 | $262 |
| Clonazepam | 70 | $257 |
| Pregabalin | 23 | $250 |
Paid to pharmacies, not to this prescriber.
Other family in Northport
- Lauren PerkinsNorthport$18K
- Mitchell CagleNorthport$13K
- Staci HardwickNorthport$12K
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.